Cargando…

The Nonantibiotic Small Molecule Cyslabdan Enhances the Potency of β-Lactams against MRSA by Inhibiting Pentaglycine Interpeptide Bridge Synthesis

The nonantibiotic small molecule cyslabdan, a labdan-type diterpene produced by Streptomyces sp. K04-0144, markedly potentiated the activity of the β-lactam drug imipenem against methicillin-resistant Staphylococcus aureus (MRSA). To study the mechanism of action of cyslabdan, the proteins that bind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koyama, Nobuhiro, Tokura, Yuriko, Münch, Daniela, Sahl, Hans-Georg, Schneider, Tanja, Shibagaki, Yoshio, Ikeda, Haruo, Tomoda, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490914/ https://www.ncbi.nlm.nih.gov/pubmed/23166602 http://dx.doi.org/10.1371/journal.pone.0048981

Ejemplares similares

The pentaglycine bridges of Staphylococcus aureus peptidoglycan are essential for cell integrity
por: Monteiro, João M., et al.
Publicado: (2019)

Anti-Infectious Agents against MRSA
por: Koyama, Nobuhiro, et al.
Publicado: (2012)

Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells
por: Badal, Sujan, et al.
Publicado: (2015)

Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines
por: Park, Chan-Su, et al.
Publicado: (2020)

Using Selection by Nonantibiotic Stressors to Sensitize Bacteria to Antibiotics
por: Maltas, Jeff, et al.
Publicado: (2020)

Reduced Growth of Staphylococcus aureus Under High Glucose Conditions Is Associated With Decreased Pentaglycine Expression
por: Luo, Zhen, et al.
Publicado: (2020)

Enhancing the antibacterial activity of polymyxins using a nonantibiotic drug
por: Krishnamurthy, Malathy, et al.
Publicado: (2019)

An oldie but a goodie: Methenamine as a nonantibiotic solution to the prevention of recurrent urinary tract infections
por: Gu, Cindy, et al.
Publicado: (2023)

High potency of sequential therapy with only β-lactam antibiotics
por: Batra, Aditi, et al.
Publicado: (2021)

Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA
por: Gonzales, Patrick R., et al.
Publicado: (2015)

Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
por: Rodriguez-Cerdeira, Carmen, et al.
Publicado: (2012)

Inhibition of WTA Synthesis Blocks the Cooperative Action of PBPs and Sensitizes MRSA to β-Lactams
por: Farha, Maya A., et al.
Publicado: (2012)

The Mechanism of Heterogeneous Beta-Lactam Resistance in MRSA: Key Role of the Stringent Stress Response
por: Kim, Choonkeun, et al.
Publicado: (2013)

A Novel Nonantibiotic, lgt-Based Selection System for Stable Maintenance of Expression Vectors in Escherichia coli and Vibrio cholerae
por: Terrinoni, Manuela, et al.
Publicado: (2018)

1066. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does β-Lactam class Matter?
por: Dilworth, Thomas J, et al.
Publicado: (2018)

Mathematical Model of the Impact of a Nonantibiotic Treatment for Clostridium difficile on the Endemic Prevalence of Vancomycin-Resistant Enterococci in a Hospital Setting
por: Grima, Daniel T., et al.
Publicado: (2012)

Effects of nonantibiotic growth promoter combinations on growth performance, nutrient utilization, digestive enzymes, intestinal morphology, and cecal microflora of broilers
por: Li, Zunyan, et al.
Publicado: (2023)

Regulation of the Expression of the β-Lactam Antibiotic-Resistance Determinants in Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Blázquez, Blas, et al.
Publicado: (2014)

Correction: The Mechanism of Heterogeneous Beta-Lactam Resistance in MRSA: Key Role of the Stringent Stress Response
por: Kim, Choonkeun, et al.
Publicado: (2014)

Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review
por: Lade, Harshad, et al.
Publicado: (2023)

2175. In vitro Potency of Ceftolozane/Tazobactam and Other Antipseudomonal β-Lactams Against P. aeruginosa
por: Abuhussain, Safa Almarzoky, et al.
Publicado: (2018)

Impact of Bicarbonate-β-Lactam Exposures on Methicillin-Resistant Staphylococcus aureus (MRSA) Gene Expression in Bicarbonate-β-Lactam-Responsive vs. Non-Responsive Strains
por: Ersoy, Selvi C., et al.
Publicado: (2021)

Molecular docking and proteomics reveals the synergistic antibacterial mechanism of theaflavin with β-lactam antibiotics against MRSA
por: Guan, Shuhan, et al.
Publicado: (2022)

Discovery of new hazimycin congeners from Kitasatospora sp. P07101
por: Koyama, Nobuhiro, et al.
Publicado: (2015)

Chemistry of Bridged Lactams: Recent Developments
por: Szostak, Roman, et al.
Publicado: (2019)

Functionalization of β-lactam antibiotic on lysozyme capped gold nanoclusters retrogress MRSA and its persisters following awakening
por: Kalita, Sanjeeb, et al.
Publicado: (2018)

Antibacterial Activity of Selected Essential Oil Compounds Alone and in Combination with β-Lactam Antibiotics Against MRSA Strains
por: Kwiatkowski, Paweł, et al.
Publicado: (2020)

The Droplet-Size Effect Of Squalene@cetylpyridinium Chloride Nanoemulsions On Antimicrobial Potency Against Planktonic And Biofilm MRSA
por: Fang, Jia-You, et al.
Publicado: (2019)

Targeting of PBP1 by β-lactams Determines recA/SOS Response Activation in Heterogeneous MRSA Clinical Strains
por: Plata, Konrad B., et al.
Publicado: (2013)

Exposure of Clinical MRSA Heterogeneous Strains to β-Lactams Redirects Metabolism to Optimize Energy Production through the TCA Cycle
por: Keaton, Mignon A., et al.
Publicado: (2013)

Purine Nucleosides Interfere with c-di-AMP Levels and Act as Adjuvants To Re-Sensitize MRSA To β-Lactam Antibiotics
por: Nolan, Aaron C., et al.
Publicado: (2022)

A small-molecule membrane fluidizer re-sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics
por: Podoll, Jessica D., et al.
Publicado: (2023)

Backbone distortions in lactam‐bridged helical peptides
por: Moazzam, Ali, et al.
Publicado: (2022)

Discovery of Nosiheptide, Griseoviridin, and Etamycin as Potent Anti-Mycobacterial Agents against Mycobacterium avium Complex
por: Hosoda, Kanji, et al.
Publicado: (2019)

Potentiation of β-Lactams against Methicillin-Resistant Staphylococcus aureus (MRSA) Using Octyl Gallate, a Food-Grade Antioxidant
por: Tamang, Migma Dorji, et al.
Publicado: (2022)

Collaterally Sensitive β-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms
por: Hashmi, Hamna Batool, et al.
Publicado: (2023)

The Anti-Repressor MecR2 Promotes the Proteolysis of the mecA Repressor and Enables Optimal Expression of β-lactam Resistance in MRSA
por: Arêde, Pedro, et al.
Publicado: (2012)

TCA Cycle-Mediated Generation of ROS Is a Key Mediator for HeR-MRSA Survival under β-Lactam Antibiotic Exposure
por: Rosato, Roberto R., et al.
Publicado: (2014)

Evolving MRSA: High-level β-lactam resistance in Staphylococcus aureus is associated with RNA Polymerase alterations and fine tuning of gene expression
por: Panchal, Viralkumar V., et al.
Publicado: (2020)

Accumulation of Succinyl Coenzyme A Perturbs the Methicillin-Resistant Staphylococcus aureus (MRSA) Succinylome and Is Associated with Increased Susceptibility to Beta-Lactam Antibiotics
por: Campbell, Christopher, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_03056aab6jct3sr2men5jlu3g8